| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ITCI | Intra-Cellular Therapies, Inc. | Durgam Suresh K. | EVP, Chief Medical Officer | Mar 07, 2024 | Sale | $66.56 | 6,450 | 429,308 | 18,892 | Mar 11, 2024, 08:31 PM | |
| ITCI | Intra-Cellular Therapies, Inc. | Durgam Suresh K. | EVP, Chief Medical Officer | Mar 11, 2024 | Sale | $65.59 | 3,712 | 243,482 | 21,336 | Mar 11, 2024, 08:31 PM | |
| ITCI | Intra-Cellular Therapies, Inc. | Durgam Suresh K. | EVP, Chief Medical Officer | Feb 26, 2024 | Sale | $70.17 | 4,112 | 288,534 | 12,200 | Feb 27, 2024, 07:58 PM | |
| ITCI | Intra-Cellular Therapies, Inc. | Durgam Suresh K. | EVP, Chief Medical Officer | Feb 02, 2024 | Sale | $67.19 | 6,167 | 414,355 | 9,540 | Feb 05, 2024, 06:02 PM | |
| ITCI | Intra-Cellular Therapies, Inc. | Durgam Suresh K. | EVP, Chief Medical Officer | Jan 02, 2024 | Option Exercise | $19.87 | 62,282 | 1,237,543 | 62,282 | Jan 04, 2024, 07:54 PM | |
| ITCI | Intra-Cellular Therapies, Inc. | Durgam Suresh K. | EVP, Chief Medical Officer | Jan 02, 2024 | Sale | $70.60 | 62,282 | 4,397,113 | 24,855 | Jan 04, 2024, 07:54 PM | |
| ITCI | Intra-Cellular Therapies, Inc. | Durgam Suresh K. | EVP, Chief Medical Officer | Dec 13, 2023 | Sale | $65.00 | 21,262 | 1,382,030 | 0 | Dec 15, 2023, 05:01 PM | |
| ITCI | Intra-Cellular Therapies, Inc. | Durgam Suresh K. | EVP, Chief Medical Officer | Jul 17, 2023 | Sale | $65.00 | 1,842 | 119,730 | 21,262 | Jul 20, 2023, 05:47 PM | |
| ITCI | Intra-Cellular Therapies, Inc. | Durgam Suresh K. | EVP, Chief Medical Officer | Mar 13, 2023 | Sale | $45.04 | 7,344 | 330,794 | 23,450 | Mar 13, 2023, 07:36 PM | |
| ITCI | Intra-Cellular Therapies, Inc. | Durgam Suresh K. | SVP, Chief Medical Officer | Feb 24, 2023 | Sale | $47.14 | 7,906 | 372,689 | 23,104 | Feb 27, 2023, 08:02 PM | |
| ITCI | Intra-Cellular Therapies, Inc. | Durgam Suresh K. | SVP, Chief Medical Officer | Feb 21, 2023 | Sale | $46.84 | 8,354 | 391,304 | 24,785 | Feb 22, 2023, 08:04 PM | |
| ITCI | Intra-Cellular Therapies, Inc. | Durgam Suresh K. | Chief Medical Officer | Mar 04, 2022 | Sale | $55.52 | 3,860 | 214,307 | 23,104 | Mar 04, 2022, 06:05 PM | |
| ITCI | Intra-Cellular Therapies, Inc. | Durgam Suresh K. | Chief Medical Officer | Mar 02, 2022 | Sale | $56.98 | 4,177 | 238,005 | 26,964 | Mar 04, 2022, 06:05 PM | |
| ITCI | Intra-Cellular Therapies, Inc. | Durgam Suresh K. | Chief Medical Officer | Feb 24, 2022 | Sale | $52.27 | 4,046 | 211,468 | 33,984 | Feb 25, 2022, 07:09 PM | |
| ITCI | Intra-Cellular Therapies, Inc. | Durgam Suresh K. | Chief Medical Officer | Feb 22, 2022 | Sale | $55.29 | 4,177 | 230,958 | 28,638 | Feb 23, 2022, 07:08 PM | |
| ITCI | Intra-Cellular Therapies, Inc. | Durgam Suresh K. | Chief Medical Officer | Jan 18, 2022 | Sale | $42.03 | 6,223 | 261,553 | 23,104 | Jan 20, 2022, 04:07 PM | |
| ITCI | Intra-Cellular Therapies, Inc. | Durgam Suresh K. | Chief Medical Officer | Jan 10, 2022 | Sale | $40.76 | 6,870 | 280,020 | 34,677 | Jan 11, 2022, 08:08 PM | |
| ITCI | Intra-Cellular Therapies, Inc. | Durgam Suresh K. | Chief Medical Officer | Feb 19, 2021 | Sale | $39.25 | 2,734 | 107,310 | 23,304 | Feb 22, 2021, 08:09 PM | |
| ITCI | Intra-Cellular Therapies, Inc. | Durgam Suresh K. | Chief Medical Officer | Jan 11, 2021 | Sale | $32.12 | 4,367 | 140,259 | 17,584 | Jan 12, 2021, 07:07 PM |
Menu